0001819790-23-000020.txt : 20230426
0001819790-23-000020.hdr.sgml : 20230426
20230426170503
ACCESSION NUMBER: 0001819790-23-000020
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230424
FILED AS OF DATE: 20230426
DATE AS OF CHANGE: 20230426
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Farrow Jeffrey S
CENTRAL INDEX KEY: 0001405253
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39614
FILM NUMBER: 23850665
MAIL ADDRESS:
STREET 1: TWO CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tarsus Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001819790
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 814717861
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 15440 LAGUNA CANYON ROAD
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: (949) 409-9820
MAIL ADDRESS:
STREET 1: 15440 LAGUNA CANYON ROAD
CITY: IRVINE
STATE: CA
ZIP: 92618
4
1
wf-form4_168254308276163.xml
FORM 4
X0407
4
2023-04-24
0
0001819790
Tarsus Pharmaceuticals, Inc.
TARS
0001405253
Farrow Jeffrey S
C/O TARSUS PHARMACEUTICALS, INC.
15440 LAGUNA CANYON ROAD, SUITE 160
IRVINE
CA
92618
0
1
0
0
See Remarks
0
Stock Option (right to buy)
14.62
2023-04-24
4
A
0
163397
0
A
2033-04-23
Common Stock
163397.0
163397
D
Restricted Stock Units
2023-04-24
4
A
0
111525
0
A
Common Stock
111525.0
111525
D
25% of the option shares shall vest on April 24, 2024, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service.
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
25% of the RSUs will vest on June 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service.
Chief Financial Officer and Chief Strategic Officer
/s/ Jeffrey Farrow
2023-04-26